Next Article in Journal
Right Ventricular Outflow Tract Stenting as Palliation of Critical Tetralogy of Fallot: Techniques and Results
Previous Article in Journal
Novel PITX2 Homeodomain-Contained Mutations from ATRIAL Fibrillation Patients Deteriorate Calcium Homeostasis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

For the Evaluation of Pacific Island Athletes, an ECG and Echocardiography Are Highly Recommended

by
Jean-Claude Chatard
1,2
1
Inter-University Laboratory of Human Movement Science, Faculty of Medicine Jacques Lisfranc, University Lyon-Saint-Etienne, CEDEX 2, 42023 Saint-Etienne, France
2
Service de Physiologie Clinique et de l’Exercice, CHU de Saint-Etienne, CEDEX 2, 42055 Saint-Etienne, France
Submission received: 13 April 2021 / Revised: 12 May 2021 / Accepted: 12 May 2021 / Published: 14 May 2021

Abstract

:
Physical exercise increases the relative risk of sudden cardiac death (SCD) in athletes when compared to a non-sporting population. Pre-participation evaluation (PPE) of athletes is thus of major importance. For Pacific Island athletes, medical guidelines recommend an echocardiography to complement a PPE including personal and family history, a physical examination and a resting twelve-lead electrocardiogram (ECG). Indeed, silent rheumatoid heart diseases found in up to 7.6% of adolescents give rise to severe valve lesions, which are the main causes of SCD in Pacific Island athletes. This short review examines the incidence rate of SCD in Pacific Island athletes and indicates how a questionnaire, physical examination, ECG and echocardiography can prevent it.

1. Introduction

In Pacific Island athletes, the estimated incidence rate of SCD is 3.9/100,000 athletes versus 1–2/100,000 athletes/year in Western countries or 34.2/100,000 athletes in specific American sports and ethnicities like Afro-Caribbean basketball players [1].
The aim of a pre-participation cardiovascular evaluation (PPE) is to detect the CV diseases that have a risk of SCD. As about 80% of these diseases are asymptomatic [2], a resting twelve-lead electrocardiogram (ECG) is recommended [3].
In Pacific Island athletes, echocardiography is also recommended. Indeed, school surveys reported a high prevalence of silent rheumatic heart disease (RHD) reaching a level of 7.6% in asymptomatic children. RDH gives rise to severe valve lesions related to acute rheumatic fever (ARF) and are the major causes of SCD.
This short review will examine the incidence rate of SCD in Pacific Island athletes and how a questionnaire, physical examination, ECG and echocardiography can prevent it.

2. Incidence Rate of Sudden Cardiac Death

In Pacific Islands athletes, SCD was studied only in New Caledonia, an island located in the South Pacific at 1200 km east of Australia and 1500 km from New Zealand [4]. During a 7-year follow up, the incidence rate was estimated to be 3.9 cases of SCD per 100,000 athletes, age range 15–20 years, and concerned a majority of Melanesian athletes who are genetically Black people (Table 1). These values are 2–3 fold higher than those in western countries but remain far fewer than the 34 cases of SCD/100,000 athletes found in Afro-Caribbean basketball players [1].

3. Differences between Countries

In Germany, the incidence rate was 0.1 to 0.2 cases of SCD/100,000 athletes [5], vs. 0.3 to 0.6 SCD/100,000 athletes in the USA [6], vs. 1/100,000 in France [7], 1.2/100,000 in Denmark [8], 2.1/100,000 in the Veneto region of Italy [9], and 3.9/100,000 in New Caledonia (Table 2) [4].

4. Differences between Sex, Ethnicity and Sports

In Pacific Islanders, the incidence rate according to sex was seven times higher for males than for females [4]. For males, football is the most practiced sport, followed by volleyball, martial arts and rugby. For females, the most important sport is volleyball. These sports represent more than 50% of all sports practiced. They are mainly anaerobic and known to serve as a trigger for ventricular arrhythmias on underlying, predominantly silent, rheumatic heart disease. A specific aerobic sport called Va’a, namely sea canoeing, is widely practiced in Polynesia.
Pacific Island athletes [4], Afro-Caribbean [15], Asian [16], West-Asian [17] and South of Far East athletes [18] have heart specificities when compared to Caucasians.
Football, running, swimming gymnastics, rugby and tennis were also reported to have a higher incidence of SCD than other less popular sports [6].

5. Causes of Sudden Cardiac Death

In 842 athletes, Maron et al. [6] found that SCD was mainly due to hypertrophic cardiomyopathy (HCM) plus indeterminate left ventricular hypertrophy (LVH) considered as possible HCM (45%), 3.5-fold more common among males than among females, as well as anomalous coronary artery (33% of females vs. 17% of males), arrhythmogenic cardiomyopathy (ACM) (13% of females vs. 4% of males) and myocarditis (6%).
In Pacific Island Athletes, the main causes of SCD are severe valve lesions of rheumatoid origin identified in 25% of athletes [4].

6. Prevention of Sudden Cardiac Death

Cardiovascular prevention has a marked place in PPE for competitive sports. Specific attention is given to males and to communities such as Melanesians, Polynesians or Afro-Caribbean groups [4,6].
Scientific committees recommend a PPE program that encompasses family and personal history, physical examination and a systematic resting twelve-lead electrocardiogram (ECG) for competitive sports in subjects between 12 and 35 years. This ECG must be repeated every 2–3 years [19].
For Pacific Island athletes, both ECG and echocardiography are recommended. Indeed, in the PPE of athletes, including systematic ECG screening, up to 3.9% of cardio-vascular abnormalities were found [4]. In school surveys using systematic echocardiographic screening, a high prevalence of RDH has been found ranging from 2.9 to 7.6% in asymptomatic school children, Melanesians and Polynesians across the developing countries Fiji, New Caledonia and New Zealand [20].

7. Questionnaire and Physical Examination

7.1. Medical History Questionnaires

For Pacific Islanders, specific attention is given to their history of ARF, an autoimmune disease that follows throat infection or reinfection with the bacterium Group A Streptococcus [21]. It is estimated that 60% of all those contracting ARF will develop RHD. Although RHD has almost disappeared from industrialized and wealthy countries, it remains the most frequent heart disease in children worldwide.
The questionnaire addresses family history, and the present and past complaints of the personal history. The short questionnaire of the AHA [22] of 14 items is recommended.

7.2. Family History

Family history focuses on (i) known RDH, valvular lesions, valve replacement surgery (ii) premature/unexpected SCD in at least one first degree relative before the age of 50, and (iii) inherited cardiac diseases like CM, Marfan syndrome, short or long QT syndrome, and severe arrhythmias. Any family history of SCD before the age of 35 years necessitates a cardiological referral to determine what further diagnostic testing is to be conducted because of the prevalent genetic transmission of HCM, long QT, ACM, Marfan Syndrome and related vascular disorders including familial biscupid aortic valve.

7.3. Personal History

Personal history focuses on previous ARF during childhood, repeated throat infections, iterative joint pain and on five determinant symptoms related to exercise: (i) syncope or near syncope, (ii) exertional chest pain, (iii) shortness of breath, (iv) palpitation, and (v) abnormal dyspnea or fatigue. The questionnaire also assesses previously known severe cardiovascular diseases. It assesses less severe cardiovascular diseases like cardiac murmur, arterial hypertension, smoking habits, recent infection, prescribed medication and results of previous systematic echocardiography.

7.4. Physical Examination

The physical examination focuses on abnormal cardiac area auscultation related to RDH such as heart murmur diastolic or systolic >2/6, fixed by respiration and reinforced after exercise, systolic click, irregular heart rhythm, and/or asymetric artery pulses especially beetwen the arms and legs (aorta coarctation), bilateral brachial blood pressure, musculoskeletal and ocular features suggestive of Marfan syndrome.

8. Standard Twelve-Lead Resting ECG

In Pacific Island athletes, the 2018 International Recommendations [23] are applicable: increased vagal tone and cardiac dimensions with bradycardia, first degree atrio-ventricular block, large QRS voltage, incomplete right bundle blanch block [18]. Early repolarization is present in about 50% of Pacific athletes, as in Afro-Caribbean athletes. Most of the TWIs located in the V2 to V4 leads are not associated with any CV disease [21].
In Pacific Island athletes, the uncommon ECG changes requiring further cardiac investigations are presented in Table 3.

9. Echocardiography and Other Investigations

In the case of Pacific Island athletes, the World Heart Foundation 2012 criteria [24] for echocardiographic diagnosis of definite or borderline RHD are applied. RHD predominantly affects the left-sided cardiac valves, >95% of mitral lesions mainly regurgitations, 1/3 being associated with aortic lesions causing regurgitation, stenosis, or mixed hemodynamic effects. Very few aortic lesions occur on their own [20].
In 2281 Pacific Island adolescents, a 4-fold increase in the incidence of the RDH was found in the 9 to 16 age group (1 to 4%). Most of them were silent. A systematic echocardiography screening was thus recommended for children aged 9–10 and for adolescent Pacific Island athletes (16 ± 1 year). For master athletes, echocardiography should also be recommended at least once between the age of 30 and 40 [20].
Other investigations, like stress ECG are of major importance for detecting disappearance or worsening of resting arrhythmias and ECG abnormalities like T wave inversion. It must be pointed out that in some low-income Pacific Islands these investigations, although highly recommended, cannot always be performed either for economic reasons or the lack of sports cardiologists or specialized medical facilities.

10. Results of Sports Pre-Participation Evaluation

In Pacific Island athletes, Chatard et al. [4] found 0.8% of athletes at risk of an SCD with a cardio-vascular disease contraindicating competitive sport and 3.9% presented a CV disease that needed a regular medical follow up. The major observation was the high prevalence (1.5%) of silent valve diseases of rheumatoid origin almost four times higher than those reported in athletes of Western and Middle Eastern countries (Table 4).
Another observation concerning the Pacific Islanders was their high HCM prevalence (2.6/1000 athletes). Only 50% were symptomatic, while all had an abnormal ECG confirming the value of an ECG examination [18,34].
In Pacific Island athletes, the HCM prevalence was close to the 3.2/1000 athletes found by Wilson et al. [17]. In these two studies, Black athletes, Melanesian and Afro-Caribbean athletes, were highly represented.
Wolff–Parkinson–White, inter-auricular or ventricular communications, long QT syndrome, ventricular arrhythmia and high blood pressure were the other most prevalent abnormalities found, confirming previous PPE studies (Table 4).
In the future, there is clearly a need for follow up and research in professional/high level athletes, undergoing structural treatment of rheumatic heart disease. Eligibility can be given as soon as the follow up of the valve repair, valvuloplasty or valve replacement is successfully performed, confirmed by echocardiography and stress ECG.

11. Conclusions

In Pacific Island athletes, there is a significant risk of SCD, especially in male adolescents, young adults and Black athletes. Most instances of SCD are due to silent arrhythmogenic cardiovascular diseases.
A systematic twelve-lead ECG would save lives. Indeed, Melanesians, of Black origin, presented with frequent TWIs in V2–V4 similar to those described in Afro-Caribbean athletes. Most of the other TWIs were associated with cardiomyopathies.
The high prevalence of RHD also confirms the importance of including a systematic echocardiography in PPE for Pacific Island athletes whatever their age.

Funding

This research was funded by a grant from Fond Pacific and the Ministère des Affaires Etrangères et du Développement International, AFD CTZ 1056 01T and a grant of Philips industry.

Acknowledgments

The authors would like to thank (i) James Pryce who has extensive experience revising medical articles for reviewing the English manuscript (ii) François Carré and Florian Espinosa for their help in the whole Pacific Islands studies.

Conflicts of Interest

The author has no conflict of interest to declare that are directly relevant to the content of this review.

References

  1. Harmon, K.G.; Asif, I.M.; Klossner, D.; Drezner, J.A. Incidence of sudden cardiac death in National Collegiate Athletic Association athletes. Circulation 2011, 123, 1594–1600. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Finocchiaro, G.; Papadakis, M.; Robertus, J.L.; Dhutia, H.; Steriotis, A.K.; Tome, M.; Mellor, G.; Merghani, A.; Malhotra, A.; Behr, E.; et al. Etiology of Sudden Death in Sports: Insights from a United Kingdom Regional Registry. J. Am. Coll. Cardiol. 2016, 67, 2108–2115. [Google Scholar] [CrossRef]
  3. Prakash, K.; Sharma, S. The Electrocardiogram in Highly Trained Athletes. Clin. Sports Med. 2015, 34, 419–431. [Google Scholar] [CrossRef]
  4. Chatard, J.C.; Espinosa, F.; Donnadieu, R.; Grangeon, J.P.; Sabot, J.M.; Guivarch, C.; Dacquin, R.; Raby, F.X.; Papouin, G.; Viali, S.; et al. Pre-participation cardiovascular evaluation in Pacific Island athletes. Int. J. Cardiol. 2019, 278, 273–279. [Google Scholar] [CrossRef] [PubMed]
  5. Bohm, P.; Scharhag, J.; Meyer, T. Data from a nationwide registry on sports-related sudden cardiac deaths in Germany. Eur. J. Prev. Cardiol. 2016, 23, 649–656. [Google Scholar] [CrossRef] [PubMed]
  6. Maron, B.J.; Haas, T.S.; Ahluwalia, A.; Murphy, C.J.; Garberich, R.F. Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry. Am. J. Med. 2016, 129, 1170–1177. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Marijon, E.; Tafflet, M.; Celermajer, D.S.; Dumas, F.; Perier, M.C.; Mustafic, H.; Toussaint, J.F.; Desnos, M.; Rieu, M.; Benameur, N.; et al. Sports-related sudden death in the general population. Circulation 2011, 124, 672–681. [Google Scholar] [CrossRef] [Green Version]
  8. Holst, A.G.; Winkel, B.G.; Theilade, J.; Kristensen, I.B.; Thomsen, J.L.; Ottesen, G.L.; Svendsen, J.H.; Haunso, S.; Prescott, E.; Tfelt-Hansen, J. Incidence and etiology of sports-related sudden cardiac death in Denmark—Implications for preparticipation screening. Heart Rhythm. 2010, 7, 1365–1371. [Google Scholar] [CrossRef] [PubMed]
  9. Corrado, D.; McKenna, W.J. Appropriate interpretation of the athlet’s electrocardiogram saves lives as well as money. Eur. Heart J. 2007, 28, 1920–1922. [Google Scholar] [CrossRef] [Green Version]
  10. Toresdahl, B.G.; Rao, A.L.; Harmon, K.G.; Drezner, J.A. Incidence of sudden cardiac arrest in high school student athletes on school campus. Heart Rhythm. 2014, 11, 1190–1194. [Google Scholar] [CrossRef]
  11. Roberts, W.O.; Stovitz, S.D. Incidence of sudden cardiac death in Minnesota high school athletes 1993–2012 screened with a standardized pre-participation evaluation. J. Am. Coll. Cardiol. 2013, 62, 1298–1301. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Landry, C.H.; Allan, K.S.; Connelly, K.A.; Cunningham, K.; Morrison, L.J.; Dorian, P. Sudden Cardiac Arrest during Participation in Competitive Sports. N. Engl. J. Med. 2017, 377, 1943–1953. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Corrado, D.; Basso, C.; Schiavon, M.; Thiene, G. Screening for hypertrophic cardiomyopathy in young athletes. N. Engl. J. Med. 1998, 339, 364–369. [Google Scholar] [CrossRef] [PubMed]
  14. Steinvil, A.; Chundadze, T.; Zeltser, D.; Rogowski, O.; Halkin, A.; Galily, Y.; Perluk, H.; Viskin, S. Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J. Am. Coll. Cardiol. 2011, 57, 1291–1296. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Basavarajaiah, S.; Boraita, A.; Whyte, G.; Wilson, M.; Carby, L.; Shah, A.; Sharma, S. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2008, 51, 2256–2262. [Google Scholar] [CrossRef] [Green Version]
  16. Kervio, G.; Pelliccia, A.; Nagashima, J.; Wilson, M.G.; Gauthier, J.; Murayama, M.; Uzan, L.; Ville, N.; Carre, F. Alterations in echocardiographic and electrocardiographic features in Japanese professional soccer players: Comparison to African-Caucasian ethnicities. Eur. J. Prev. Cardiol. 2013, 20, 880–888. [Google Scholar] [CrossRef]
  17. Wilson, M.G.; Chatard, J.C.; Carre, F.; Hamilton, B.; Whyte, G.P.; Sharma, S.; Chalabi, H. Prevalence of electrocardiographic abnormalities in West-Asian and African male athletes. Brit. J. Sports Med. 2012, 46, 341–347. [Google Scholar] [CrossRef]
  18. Ozo, U.; Sharma, S. The Impact of Ethnicity on Cardiac Adaptation. Eur. Cardiol. 2020, 15, e61. [Google Scholar] [CrossRef]
  19. Chatard, J.C.; Mujika, I.; Goiriena, J.J.; Carre, F. Screening young athletes for prevention of sudden cardiac death: Practical recommendations for sports physicians. Scand. J. Med. Sci. Sports 2016, 26, 362–374. [Google Scholar] [CrossRef]
  20. Chatard, J.C.; Dubois, T.; Espinosa, F.; Kamblock, J.; Ledos, P.H.; Tarpinian, E.; Da Costa, A. Screening Rheumatic Heart Disease in 1530 New Caledonian Adolescents. J. Am. Heart Assoc. 2020, 9, e015017. [Google Scholar] [CrossRef]
  21. Carapetis, J.R.; McDonald, M.; Wilson, N.J. Acute rheumatic fever. Lancet 2005, 366, 155–168. [Google Scholar] [CrossRef]
  22. Maron, B.J.; Thompson, P.D.; Ackerman, M.J.; Balady, G.; Berger, S.; Cohen, D.; Dimeff, R.; Douglas, P.S.; Glover, D.W.; Hutter, A.M., Jr.; et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: A scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation. Circulation 2007, 115, 1643–1655. [Google Scholar] [PubMed] [Green Version]
  23. Sharma, S.; Drezner, J.A.; Baggish, A.; Papadakis, M.; Wilson, M.G.; Prutkin, J.M.; La Gerche, A.; Ackerman, M.J.; Borjesson, M.; Salerno, J.C.; et al. International recommendations for electrocardiographic interpretation in athletes. Eur. Heart J. 2018, 39, 1466–1480. [Google Scholar] [CrossRef] [PubMed]
  24. Remenyi, B.; Wilson, N.; Steer, A.; Ferreira, B.; Kado, J.; Kumar, K.; Lawrenson, J.; Maguire, G.; Marijon, E.; Mirabel, M.; et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart diseas—An evidence-based guideline. Nat. Rev. Cardiol. 2012, 9, 297–309. [Google Scholar] [CrossRef] [Green Version]
  25. Fuller, C.M.; McNulty, C.M.; Spring, D.A.; Arger, K.M.; Bruce, S.S.; Chryssos, B.E.; Drummer, E.M.; Kelley, F.P.; Newmark, M.J.; Whipple, G.H. Prospective screening of 5615 high school athletes for risk of sudden cardiac death. Med. Sci. Sports Exerc. 1997, 29, 1131–1138. [Google Scholar] [CrossRef]
  26. Papadakis, M.; Carre, F.; Kervio, G.; Rawlins, J.; Panoulas, V.F.; Chandra, N.; Basavarajaiah, S.; Carby, L.; Fonseca, T.; Sharma, S. The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. Eur. Heart J. 2011, 32, 2304–2313. [Google Scholar] [CrossRef]
  27. Price, D.E.; McWilliams, A.; Asif, I.M.; Martin, A.; Elliott, S.D.; Dulin, M.; Drezner, J.A. Electrocardiography-inclusive screening strategies for detection of cardiovascular abnormalities in high school athletes. Heart Rhythm. 2014, 11, 442–449. [Google Scholar] [CrossRef]
  28. Magalski, A.; Maron, B.J.; Main, M.L.; McCoy, M.; Florez, A.; Reid, K.J.; Epps, H.W.; Bates, J.; Browne, J.E. Relation of race to electrocardiographic patterns in elite American football players. J. Am. Coll. Cardiol. 2008, 51, 2250–2255. [Google Scholar] [CrossRef] [Green Version]
  29. Hevia, A.C.; Fernandez, M.M.; Palacio, J.M.; Martin, E.H.; Castro, M.G.; Reguero, J.J. ECG as a part of the preparticipation screening programme: An old and still present international dilemma. Brit. J. Sports Med. 2011, 45, 776–779. [Google Scholar] [CrossRef]
  30. Wilson, M.G.; Basavarajaiah, S.; Whyte, G.P.; Cox, S.; Loosemore, M.; Sharma, S. Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies: The role of electrocardiography. Brit. J. Sports Med. 2008, 42, 207–211. [Google Scholar] [CrossRef] [Green Version]
  31. Menafoglio, A.; Di Valentino, M.; Segatto, J.M.; Siragusa, P.; Pezzoli, R.; Maggi, M.; Romano, G.A.; Moschovitis, G.; Wilhelm, M.; Gallino, A. Costs and yield of a 15-month preparticipation cardiovascular examination with ECG in 1070 young athletes in Switzerland: Implications for routine ECG screening. Brit. J. Sports Med. 2014, 48, 1157–1161. [Google Scholar] [CrossRef] [PubMed]
  32. Mayer, F.; Bonaventura, K.; Cassel, M.; Mueller, S.; Weber, J.; Scharhag-Rosenberger, F.; Carlsohn, A.; Baur, H.; Scharhag, J. Medical results of preparticipation examination in adolescent athletes. Brit. J. Sports Med. 2012, 46, 524–530. [Google Scholar] [CrossRef] [PubMed]
  33. Baggish, A.L.; Hutter, A.M., Jr.; Wang, F.; Yared, K.; Weiner, R.B.; Kupperman, E.; Picard, M.H.; Wood, M.J. Cardiovascular screening in college athletes with and without electrocardiography: A cross-sectional study. Ann. Intern. Med. 2010, 152, 269–275. [Google Scholar] [CrossRef]
  34. Asif, I.M.; Harmon, K.G. Incidence and Etiology of Sudden Cardiac Death: New Updates for Athletic Departments. Sports Health 2017, 9, 268–279. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Table 1. Sudden cardiac death (SCD) in athletes and non-athletes registered between 2012 and 2014 in the New Caledonian population 10–40 age group: Poly = Polynesian, Mel = Melanesian, HCM = hypertrophic cardiomyopathy, WPW = Wolff–Parkinson–White, RHD = rheumatic heart disease, UR = un resuscitated after electric shock, * resuscitation after an SC arrest and an electric shock, ** estimation.
Table 1. Sudden cardiac death (SCD) in athletes and non-athletes registered between 2012 and 2014 in the New Caledonian population 10–40 age group: Poly = Polynesian, Mel = Melanesian, HCM = hypertrophic cardiomyopathy, WPW = Wolff–Parkinson–White, RHD = rheumatic heart disease, UR = un resuscitated after electric shock, * resuscitation after an SC arrest and an electric shock, ** estimation.
SubjectsCategorynSCDAgeSexSportsEthnicityCause
Athletes
(A)
Elite and Interregional362118FShot putPolynesianProlonged QT suspicion
Elite school of sports4310 M
Other registered athletes42,655117MBadmintonMétisVentricular rhythm issue *
118MFootballMelanesianHCM
Not registered athletes **7800316
15
20
M
M
M
Basketball
Badminton
Golf
Melanesian
Unknown
Polynesian
Ventricular rhythm issue,
Unknown, UR
Unknown
Army **1000118MRunningMelanesianVentricular rhythm issue, possible
HCM previous inverted T waves
Total 4.4/100,000/year53,0417
Non
Athletes
(B)
8---MelanesianConsequence of RHD
6---MelanesianAneurysms
5---MelanesianMassive heart infarction
2---MelanesianPulmonary embolism
1---MelanesianMellitus coma
10---MelanesianUnknown
Total 18.3/100,000/year58,26732-----
(A)+(B)Total 11.7/100,000/year111,30839-----
Table 2. Incidence rate of sudden cardiac death related to exercise in different countries: comparison between male and female, White and Black athletes, and sports.
Table 2. Incidence rate of sudden cardiac death related to exercise in different countries: comparison between male and female, White and Black athletes, and sports.
AuthorsCountryStudied
Period
Age
Years
CategoryTotal
Million
Incidence Rate
/100,000
Chatard et al., 2019 [4]New
Caledonia
2011–201710–40Elite athletes
Melanesian+Polynesian+Wallisian+White
3.9
2012–201410–40Registered and non-registered athletes
Melanesian+Polynesian+Wallisian+White
0.1111.7
Harmon et al., 2011 [1]USA2004–200815–24Black + White1.92.3
Black0.35.7
White1.61.7
Black male 7.7
Basketball 8.8
Male 14.3
Female 2.6
Division I0.834.3
Division I Black male 32
Swimming-4.3
Football-2.6
Cross country-2.4
Maron et al., 2016 [6]USA1980–20118–39White + Nonwhite>800.6
Toresdahl et al., 2014 [10]USA2009–2011CollegeBlack + White4.11.1
Roberts et al., 2013 [11]Minnesota1993–201212–19High school athletes1.70.2
Landry et al., 2017 [12]Canada2009–201412–45 18.50.8
Holst et al., 2010 [8]Denmark2000–200612–35White1.61.2
Marijon et al., 2011 [7]France2005–201010–35White13.41.0
Bohm et al., 2016 [5]Germany2012–201410–79 0.1–0.2
Corrado et al., 1998 [13]Italy1979–200412–35White36.12.1
Steinvil et al., 2011 [14]Israel1985–200910–40 2.6
Table 3. Twelve-lead ECG criteria requiring further cardiac investigations in Pacific Island athletes [4].
Table 3. Twelve-lead ECG criteria requiring further cardiac investigations in Pacific Island athletes [4].
Heart FrequencyBradycardia < 30 bpm or Pauses ≥ 3 s
P waveIn I and II amplitude > 2.5 mm and/or duration > 120 ms *
In V1–V2, >1 mm in depth, >40 ms in duration *
Atrial fibrillation, flutter, supraventricular tachycardia
PR intervalPR < 120 ms and delta wave at the beginning of QRS
and sometimes inverted T waves = WPW.
Atrio-ventricular block 1° ≥ 400 ms
Mobitz II, 2° block without Wenckebach phenomenon.
3° complete AV block
Q waveQ/R ratio 25% or > 40 ms duration in 2 or more leads
except III and aVR
QRS complexDelta wave
LBBB > 120 ms,
RBBB > 120 ms *
Any QRS > 140 ms
Left and right axis deviation < −30° > 120° *
R wave in V1 > 7 mm *
R/S > 1 in V1–V2 *, R/S <1 in V5–V6 *
Brugada Type 1
Epsilon wave
ST segmentDepression > 0.5 mm in 2 or more contiguous leads
Depression > 1 mm in any lead
Inverted T wave≥1 mm in depth in 2 or more contiguous leads
Before puberty in any lead except III, VR, V1, V2, V3
Post puberty and adult in any lead except III, VR, V1
Except V2, if IRBBB
Except V2, V3 and V4 in Black athletes
QTc>470 ms in male, >480 ms in female
<340 ms in any athlete
Ventricular premature beat≥2 premature ventricular beats per 10 s tracing
Doubletss, triplets and non-sustained ventricular tachycardia
ECG: electrocardiogram, IRBBB: incomplete right bundle-branch block, LBBB: left bundle-branch block, QTc: corrected QT duration (Bazet formula), WPW: Wolff–Parkinson–White. * If isolated, asymptomatic and no family or personal history with no need for further investigation, if in association with 2 or more * criteria, further investigation is required [23].
Table 4. Number of cardiac diseases found after athlete screening in 13 studies. M: male, Cat: athlete category, CI: contra-indication to sports, MC: myocardiopathy, LVH: left ventricular hypertrophy, WPW: Wolff–Parkinson–White, QT: long QTc, VA: ventricular arrhythmia, AHT: arterial hypertension, Val: valvulopathy, IAC: interatrial communication, Brug: Brugada.
Table 4. Number of cardiac diseases found after athlete screening in 13 studies. M: male, Cat: athlete category, CI: contra-indication to sports, MC: myocardiopathy, LVH: left ventricular hypertrophy, WPW: Wolff–Parkinson–White, QT: long QTc, VA: ventricular arrhythmia, AHT: arterial hypertension, Val: valvulopathy, IAC: interatrial communication, Brug: Brugada.
StudiesnM%CatEthnyAgeCIMCLVHWPWQTVAAHTValIACBrug
Corrado et al., 1998 [13]33,73585AIta19621346 •4437121168133
Fuller et al., 1997 [25]561560HSCa ?13–192203 *1015204300
Basavarajaiah et al., 2008 [15]350075E98% Ca20.515053°6900920
Papadakis et al., 2011 [26]2745100A66% Ca
33% Ba
14–35124112°43022551
Chatard et al., 2019 [4]228169E31% Mel
29% Poly
21% Cau
20% Met
10–40188-65863580
Price et al., 2014 [27]201771S34% Ca
31% Ba
14–18511 •4100300
Magalski et al., 2008 [28]1959100EF67% Ba
31% Ca
23006 •000?000
Hevia et al., 2012 [29]122096SCa ?23228 •4040000
Wilson et al., 2012 [17]1220100AP66%Wa
25% Ba
22.67413 •21110210
Wilson et al., 2008 [30]1074100JCa ?15.8910431???0
Menafoglio et al., 2013 [31]107075A98%Ca19.74003101500
Mayer et al., 2012 [32]73357ESCa ?12.341030001030
Baggish et al., 2010 [33]50861S68% Ca
10% Ba
19322 *0000700
Total57,677----722572048160150227252--
Mean percentage 82--19.41.31.00.350.140.100.260.400.43--
A: amateur, AP: amateur and professional, E: elite, ES, elite school of sports, EF: elite football players, HS: high school, J: junior, S: student athletes. Ba: Black, Ca: Caucasian, Ita: Italian, Wa: West-asian, Arabic, Left ventricular thickness: * ≥11 mm, ° ≥12 mm, • 13   mm .
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Chatard, J.-C. For the Evaluation of Pacific Island Athletes, an ECG and Echocardiography Are Highly Recommended. Hearts 2021, 2, 270-277. https://0-doi-org.brum.beds.ac.uk/10.3390/hearts2020021

AMA Style

Chatard J-C. For the Evaluation of Pacific Island Athletes, an ECG and Echocardiography Are Highly Recommended. Hearts. 2021; 2(2):270-277. https://0-doi-org.brum.beds.ac.uk/10.3390/hearts2020021

Chicago/Turabian Style

Chatard, Jean-Claude. 2021. "For the Evaluation of Pacific Island Athletes, an ECG and Echocardiography Are Highly Recommended" Hearts 2, no. 2: 270-277. https://0-doi-org.brum.beds.ac.uk/10.3390/hearts2020021

Article Metrics

Back to TopTop